References
- Strosberg JR, Fine RL, Choi J, et al. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer 2011;117:268–275.
- Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome:clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748–1757.
- Bodell WJ, Gaikwad NW, Miller D, et al. Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 2003;12:545–551.
- Brada M, Judson I, Beale P, et al. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br J Cancer 1999;81:1022–1030.
- Geiger H, Schleimer D, Nattamai KJ, et al. Mutagenic potential of temozolomide in bone marrow cells in vivo. Blood 2006;107: 3010–3011.
- Hayman JA, Callahan JW, Herschtal A, et al. Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging. Int J Radiat Oncol Biol Phys 2011;79:847–852.
- Chou KN, Lin YC, Liu MY, et al. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient. J Clin Neurosci 2014;21:701–704.
- Tan CW, See SJ, Tham CK, et al. Treatment-related acute myeloid leukaemia after temozolomide for glioblastoma multiforme. Ann Acad Med Singapore 2014;43:334–337.
- Momota H, Narita Y, Miyakita Y, et al. Secondary hematological malignancies associated with temozolomide in patients with glioma. Neuro Oncol 2013;15:1445–1450.
- Ogura M, Todo T, Tanaka M, et al. Temozolomide may induce therapy-related acute lymphoblastic leukaemia. Br J Haematol 2011;154:663–665.
- Natelson EA, Pyatt D. Temozolomide-induced myelodysplasia. Adv Hematol 2010;2010:760402.
- Shaikh AJ, Masood N. Acute lymphoblastic leukemia subsequent to temozolomide use in a 26-year-old man: a case report. J Med Case Rep 2010;4:274.
- Chamberlain MC, Raizer J. Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia. J Neurooncol 2009;93:229–232.
- De Vita S, De Matteis S, Laurenti L, et al. Secondary Ph+ acute lymphoblastic leukemia after temozolomide. Ann Hematol 2005;84:760–762.